Pulmonx
Sri has nearly 20 years of experience in the medical device industry. He joined Pulmonx in 2008 and served as Sr. Director/VP of R&D and Operations prior to being named Chief Technical Officer. He started his medical device career at Medtronic AneuRx/AVE and subsequently held management positions in engineering and operations at Bacchus Vascular (Covidien), Foxhollow, and ev3. Previously, he worked in the engineering consulting and energy sectors. Sri holds a BS in Production Engineering from the University of Bombay and an MS in Industrial Engineering from the University of Alabama.
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1